Gooren L J, van der Veen E A, van Kessel H, Harmsen-Louman W, Wiegel A R
Int J Androl. 1984 Feb;7(1):53-60. doi: 10.1111/j.1365-2605.1984.tb00759.x.
There is evidence that prolactin may be involved in testicular steroidogenesis, and we have therefore investigated whether there is feedback regulation of androgens/oestrogens on prolactin secretion in the human male. To assess this we have measured basal and TRH-stimulated prolactin levels in: Six eugonadal men before and after 2 weeks' administration of the aromatase inhibitor delta'-testolactone, which led to a fall in oestradiol levels with unchanged levels of testosterone. In these patients, prolactin levels decreased. Six eugonadal subjects before and after 6 weeks' administration of dihydrotestosterone undecanoate. In these subjects, prolactin levels decreased. Six agonadal subjects, tested after 12 weeks' treatment with dihydrotestosterone undecanoate and compared to: Six agonadal subjects who received no sex steroid treatment. Again, it was found that dihydrotestosterone treatment decreased prolactin levels in patients from Group C. Six eugonadal subjects were also studied before and after 6 weeks' administration of the androgen receptor antagonist, spironolactone, and this treatment increased Prl secretion. It is concluded that in the human male, endogenous oestrogens increase prolactin secretion whilst exogenous/endogenous androgens decrease prolactin secretion.
有证据表明催乳素可能参与睾丸类固醇生成,因此我们研究了在男性中雄激素/雌激素对催乳素分泌是否存在反馈调节。为了评估这一点,我们测量了以下人群基础及促甲状腺激素刺激后的催乳素水平:6名性腺功能正常的男性,在服用芳香化酶抑制剂δ'-睾酮内酯2周前后,这导致雌二醇水平下降而睾酮水平不变。在这些患者中,催乳素水平降低。6名性腺功能正常的受试者,在服用十一酸双氢睾酮6周前后。在这些受试者中,催乳素水平降低。6名性腺功能减退的受试者,在接受十一酸双氢睾酮治疗12周后进行测试,并与:6名未接受性类固醇治疗的性腺功能减退受试者进行比较。同样,发现双氢睾酮治疗降低了C组患者的催乳素水平。6名性腺功能正常的受试者在服用雄激素受体拮抗剂螺内酯6周前后也进行了研究,这种治疗增加了催乳素的分泌。得出的结论是,在男性中,内源性雌激素增加催乳素分泌,而外源性/内源性雄激素降低催乳素分泌。